Net profit of Supriya Lifescience declined 22.07% to Rs 34.79 crore in the quarter ended June 2025 as against Rs 44.64 crore during the previous quarter ended June 2024. Sales declined 9.69% to Rs 145.07 crore in the quarter ended June 2025 as against Rs 160.63 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 145.07 | 160.63 | -10 |
| OPM % | 35.64 | 38.94 | - |
| PBDT | 53.87 | 64.43 | -16 |
| PBT | 47.42 | 59.77 | -21 |
| NP | 34.79 | 44.64 | -22 |